CAS 1047634-65-0
:Uprosertib
Description:
Uprosertib, with the CAS number 1047634-65-0, is a small molecule inhibitor primarily targeting the protein kinase AKT, which plays a crucial role in various cellular processes, including metabolism, proliferation, and survival. This compound is classified as a selective inhibitor, demonstrating potential therapeutic applications in oncology, particularly in cancers characterized by aberrant AKT signaling. Uprosertib has been investigated in clinical trials for its efficacy in combination with other treatments, aiming to enhance anti-tumor activity. Its chemical structure features specific functional groups that contribute to its binding affinity and selectivity for the AKT enzyme. The pharmacokinetic properties of Uprosertib, including absorption, distribution, metabolism, and excretion, are essential for determining its clinical utility and dosing regimens. As with many targeted therapies, understanding the resistance mechanisms and potential side effects is critical for optimizing its use in cancer treatment. Overall, Uprosertib represents a promising avenue in the development of targeted therapies aimed at improving outcomes for patients with certain malignancies.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
Uprosertib
CAS:Uprosertib (GSK2141795) is a potent, selective Akt broad-spectrum inhibitor for Akt1/Akt2/Akt3.Cost-effective and quality-assured.Formula:C18H16Cl2F2N4O2Purity:95.62% - 99.73%Color and Shape:SolidMolecular weight:429.25Uprosertib-13C4d3
CAS:Controlled ProductFormula:C14C4H13D3Cl2F2N4O2Color and Shape:NeatMolecular weight:436.237Uprosertib
CAS:<p>Inhibitor of ALK kinases; broad spectrum</p>Formula:C18H16Cl2F2N4O2Purity:Min. 95%Molecular weight:429.25 g/mol
